AzTrials
AzTrials

Head TraumaNCT03291964

Rapid MRI for Acute Pediatric Head Trauma

An observational study of Head Trauma and Image, Body, run by Oregon Health and Science University at 1 site in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Pediatric head trauma is a leading cause of morbidity and mortality for children/adolescents. The current standard of care regarding imaging modality when concerned for an acute head injury is CT. This exposes children to radiation that may predispose to future malignancy. Read more about this study

Who is it for?
Ages 0 to 14 years
Conditions the study is for
Head Trauma, Image, Body
What is being tested?
Rapid Brain MRI
How many people
76 participants
Where
1 siteUnited States
Study dates
3 Sep 2017to 1 Dec 2019
Phase
Observational
Are there results?
Yes, posted in the registrySummary in the doctors' view

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 0 to 14 years
  • All sexes
  • Child

Study population: All pediatric trauma patients being evaluated with a head CT for acute intracranial injury

Who may be able to join

  • The patient presents to the pediatric emergency department or trauma system at OHSU or is a trauma system transfer patient to OHSU
  • Age 0-14 years.
  • Being evaluated for a traumatic head injury and attending physician decides to obtain a head CT.
  • Clinically stable for additional testing: provider deems it safe to obtain a QbMRI in the ED without deep sedation

Who cannot join

  • Subject is from outside hospital and head CT was performed greater than 6 hours prior
  • Subject is from outside hospital and initial head CT is not in our imaging system for review
  • History of intracranial surgery
  • History of metallic implants making MRI contraindicated
  • Decompressive surgery prior to QbMRI

Trial locations and contacts

1 site in 1 country.

United States1 site
  • OHSU

    Portland, Oregon, 97239

Other trials in United States

About this study

Official title: QuickBrain MRI for Acute Pediatric Head Trauma

Pediatric head trauma is a leading cause of morbidity and mortality for children/adolescents. The current standard of care regarding imaging modality when concerned for an acute head injury is CT. This exposes children to radiation that may predispose to future malignancy. Rapid MRI is a test that eliminates radiation and has expanded uses in multiple other areas. This study is evaluating it for pediatric acute head trauma.

Read the detailed description

Initial retrospective study suggests that QbMRI has adequate sensitivity to detect acute ciTBIs in children. This preliminary study included all pediatric trauma patients presenting to OHSU from 2/2010 through 12/2013 who had both a head CT and QbMRI. The current standard of care in the pediatric ICU at OHSU is for patients admitted with an acute head injury to undergo routine QbMRI follow up to assess status of the injury rather than a repeat head CT. Our study team collected clinical data on these patients that included clinical interventions and then de-identified all head CT and QbMRI images for this cohort. The images were then independently reviewed by 2 neuroradiology fellows at OHSU (Please refer to Figure 1). The sensitivity of QbMRI to detect any radiographic injury was 85% (95% CI: 73, 93), but increased when evaluating clinically important TBIs to 100% (95% CI: 89, 100). The largest limitation of this study was the variable and often long time interval between acquisition of the head CT and QbMRI. The average length of time between the initial head CT and QbMRI was 27.5 hours with only 41% receiving both imaging tests within 12 hours of each other. Also, preliminary data was collected by retrospective review. As such, it is very promising that initial study had high sensitivity, but further prospective pilot data with a shorter interval between the index and reference test is needed to assess the discrepancy between the two types of lesions (radiographic vs clinically important) and feasibility of obtaining qbMRI in the setting of acute pediatric head trauma. While this study did not miss any clinically important TBIs, on further review of radiographic "missed lesions", the study pediatric neurosurgeon noted signs of a healing bleed. This may suggest that they were "missed" because they were healed rather than present and not seen. All patients that did not have a lesion identified on QbMRI did not require significant clinical interventions and only underwent periods of observation in the hospital. However, this raises the need for a prospective trial to obtain QbMRI imaging within the same time frame sequentially after the initial head CT.

Being tested
Rapid Brain MRI
Medical subject headings
Craniocerebral Trauma

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Rapid Brain MRIDiagnostic test

    Children undergoing head CT for evaluation of acute head injury will also undergo rapid brain MRI with GRE sequence that is specific for blood. Their clinical care will not change at all based on the MRI.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Sensitivity: Percentage of MRIs Correctly Identifying Clinically Important Intracranial Injury (True Positives)

    Sensitivity of Rapid MRI for detection of a clinically important intracranial injury: Percentage of MRIs identifying clinically important intracranial injury. Sensitivity was calculated as the number of true positives divided by "true positive plus false negative". True positive was defined based on meeting clinical criteria for a clinically important TBI and if the imaging found the injury.

    Measured: within 6 hours from the initial head CT

Secondary outcomes (2)
  1. Time From Order to Obtaining MRI

    minutes

    Measured: During initial ER stay within 3 hours from time of entry to the ER

  2. Need for Anxiolysis Medication (Defined as Benzodiazepines for Imaging Indication)

    Number of patients requiring medication to obtain imaging

    Measured: During initial ER stay within 3 hours from time of entry to the ER

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted25 Sep 2017
  2. Study start3 Sep 2017
  3. Primary completion1 Aug 2019
  4. Study completion1 Dec 2019

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
76 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03291964
Sponsor's protocol ID
17254
Status last verified
Apr 2022
First submitted
27 Jun 2017
Last updated
26 Jan 2023
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

An observational study of Head Trauma and Image, Body, run by Oregon Health and Science University at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 26 Jan 2023. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Yes. Results are posted in the registry (first posted 26 Jan 2023). A summary is in the For doctors view, and the full results are on ClinicalTrials.gov.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Sensitivity: Percentage of MRIs Correctly Identifying Clinically Important Intracranial Injury (True Positives) (time frame: within 6 hours from the initial head CT). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 26 Jan 2023.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in